Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults clinical trials

Explore recruiting prevention of stroke and systemic embolism in adult patients with non valvular atrial fibrillation nvaf with one or more risk factors such as prior stroke or transient ischaemic attack tia age 75 years hypertension diabetes mellitus symptomatic heart failure nyha class ii treatment of deep vein thrombosis dvt and pulmonary embolism pe and prevention of recurrent dvt and pe in adults clinical trials.

Also recruiting in Europe

Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study comparing the new drug PG413 produced by Celon Pharma SA with the drug Eliquis available on the market in healthy volunteers.

Poland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A randomized, open-label, single dose, 2-way crossover bioequivalence study comparing apixaban 5 mg hard capsules (PG412 [Celon Pharma]) vs apixaban 5 mg film-coated tablets (Eliquis [Bristol-Myers Squibb]) under fasting conditions in healthy volunteers

Poland

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults trials by city

Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Toronto Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Vancouver Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Montreal Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Calgary Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Edmonton Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Ottawa Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Winnipeg Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Quebec City Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Hamilton Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Kitchener Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in London Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Halifax Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in New York Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Los Angeles Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Chicago Prevention Of Stroke And Systemic Embolism In Adult Patients With Non Valvular Atrial Fibrillation Nvaf With One Or More Risk Factors Such As Prior Stroke Or Transient Ischaemic Attack Tia Age 75 Years Hypertension Diabetes Mellitus Symptomatic Heart Failure Nyha Class Ii Treatment Of Deep Vein Thrombosis Dvt And Pulmonary Embolism Pe And Prevention Of Recurrent Dvt And Pe In Adults in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease